Replimune Group Inc
NASDAQ:REPL

Watchlist Manager
Replimune Group Inc Logo
Replimune Group Inc
NASDAQ:REPL
Watchlist
Price: 9.57 USD 6.57% Market Closed
Market Cap: 737m USD

Wall Street
Price Targets

REPL Price Targets Summary
Replimune Group Inc

Wall Street analysts forecast REPL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REPL is 22 USD with a low forecast of 14.14 USD and a high forecast of 32.55 USD.

Lowest
Price Target
14.14 USD
48% Upside
Average
Price Target
22 USD
130% Upside
Highest
Price Target
32.55 USD
240% Upside
Replimune Group Inc Competitors:
Price Targets
PYC
PYC Therapeutics Ltd
190% Upside
IMNM
Immunome Inc
176% Upside
XGN
Exagen Inc
11% Upside
ITOS
Iteos Therapeutics Inc
20% Upside
LXRX
Lexicon Pharmaceuticals Inc
323% Upside
SRZN
Surrozen Inc
364% Upside
GLPG
Galapagos NV
18% Upside
ABBV
Abbvie Inc
16% Upside

Revenue
Forecast

Revenue Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Replimune Group Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REPL's stock price target?
Price Target
22 USD

According to Wall Street analysts, the average 1-year price target for REPL is 22 USD with a low forecast of 14.14 USD and a high forecast of 32.55 USD.

Back to Top